Therefore, ATF3 is a key transcription factor that modulates glucolipid metabolism and related metabolic diseases by controlling a metabolic and inflammatory network through specific organs and cell types and inter-organ crosstalk (Figure 3). Here, ATF3 is linked to metabolic disease.